The Effect of High Knowledge on Diabetes Type 2 and Strong Belief in Medicine with Non-Adherence of Anti Diabetic Medication: A Meta-Analysis
Abstract
Background: By 2045, the number of people with diabetes mellitus (DM) was expected to increase from 424.9 million in 2017. Healthcare professionals have had a difficult time managing diabetes because of nonadherence to therapy. Additionally, the efforts made to clarify and enhance patient adherence to their medication are not always successful. This study investigated the factors such as high knowledge on diabetes type 2 and strong belief in medicine that lead to medication non-adherence in adults.
Subjects and Method: This article was a systematic review and meta-analysis study conducted by searching for articles from online databases such as EBSCO, ProQuest, and PubMed. Populations: adults with diabetes mellitus; Intervention: a strong belief in anti-diabetic medication and high knowledge of diabetes mellitus; Comparison: a weak belief or none in anti-diabetic medication and little knowledge of diabetes mellitus; Outcome: non-adherence of anti-diabetic medication. The independen variables is strong belief and high knowledge, the dependen variable is non-adherence to anti-diabetic medication. The inclusion criteria for this study were full articles using a cross-sectional study, with the publication year until 2022. We conduct the analysis using RevMan 5.3 software.
Results: A total of 6 articles reviewed in the meta-analysis (consisted 4 articles in each variables), from countries: Ethiopia, Australia, Uganda, Iran, Palestine and China, showed that respondents with strong belief in anti-diabetic medicines (aOR= 0.66; 95% CI= 0.48 to 0.90; p= 0.008) and high knowledge of diabetes mellitus (aOR= 0.85; 95% CI= 0.79 to 0.93; p= 0.0005) had lower level of non-adherence to anti-diabetic medication.
Conclusion: A strong belief in anti-diabetic medicines and high knowledge of diabetes mellitus can lower non-adherence to anti-diabetic medication.
Keywords: diabetes mellitus type 2, medication adherence, predictors
Correspondence: Sri Iswahyuni. Study Program of Nursing, School of Health Sciences Mamba’ul ‘Ulum Surakarta. Jl. Ring Road 03, Surakarta 57127, Jawa Tengah. Email: iswahyunisri@yahoo.co.id. Mobile: +62 815-6720-715.
Indonesian Journal of Medicine (2022), 07(02): 150-160
https://doi.org/10.26911/theijmed.2022.07.02.04
References
ADA (2013). Standards of medical care in diabetes–2013. Dia. Diabetes Care. 36(1): S11–S66.
Alatawi YM, Kavookjian J, Ekong G, Alrayees MM (2016). The association between health beliefs and medication adherence among patients with type 2 diabetes. RSAP. 12(6): 914–925. doi: 10.1016/j.sapharm.2015.11.006.
Alexopoulos AS, Yancy WS, Edelman D, Coffman CJ, Jeffreys AS, Maciejewski ML, Voils CI, et al. (2021). Clinical associations of an updated medication effect score for measuring diabetes treatment intensity. Chronic Illness. 17(4): 451–462. doi: 10.1177/1742395319884096.
Ali M, Alemu T, Sada O (2017). Medication adherence and its associated factors among diabetic patients at Zewditu Memorial Hospital, Addis Ababa, Ethiopia. BMC Research Notes. 10(1): 676. doi: 10.1186/s1310401730257.
Arifulla M, John LJ, Sreedharan J, Muttappallymyalil J, Basha SA (2014). Patient’s Adherence to AntiDiabetic Medications in a Hospital at Ajman, UAE. Malays J Med Sci: MJMS. 21(1): 44–49.
Bagonza J, Rutebemberwa E, Bazeyo W (2015). Adherence to anti diabetic medication among patients with diabetes in eastern Uganda; a cross sectional study. BMC Health Serv. Res. 15: 168. doi: 10.1186/s1291301508205.
Conn VS, Ruppar TM (2017). Medication adherence outcomes of 771 intervention trials: Systematic review and metaanalysis. Prev. Med. 99: 269–276. doi: 10.1016/j.ypmed.2017.03.008.
Cutler RL, FernandezLlimos F, Frommer M, Benrimoj C, GarciaCardenas V (2018). Economic impact of medication nonadherence by disease groups: a systematic review. BMJ Open. 8(1): e016982. doi: 10.1136/bmjopen2017016982
DACA (2010). Standard treatment guideline for primary hospitals. (2nd ed). Addis Ababa.
Dhippayom T, Krass I (2015). Medicationtaking behaviour in New South Wales patients with type 2 diabetes: an observational study. Aust. J. Prim. Health. 21(4): 429–437. doi: 10.1071/PY14062.
Elsous A, Radwan M, AlSharif H, Abu Mustafa A (2017). Medications Adherence and Associated Factors among Patients with Type 2 Diabetes Mellitus in the Gaza Strip, Palestine. Front Endocrinol. 8: 100. doi: 10.3389/fendo.2017.00100.
Gautam A, Bhatta DN, Aryal UR (2015). Diabetes related health knowledge, attitude and practice among diabetic patients in Nepal. BMC Endocr. Disord. 15(1): 25. doi: 10.1186/s1290201500 216.
Gebremedhin T, Workicho A, Angaw DA (2019). Healthrelated quality of life and its associated factors among adult patients with type II diabetes attending Mizan Tepi University Teaching Hospital, Southwest Ethiopia. BMJ Open Diabetes Res. Care. 7(1): e000577. doi: 10.1136/bmjdrc2018000577.
Habebo TT, Pooyan EJ, Mosadeghrad AM, Babore GO, Dessu BK (2020). Prevalence of poor diabetes selfmanagement behaviors among ethiopian diabetes mellitus patients: A systematic review and metaanalysis. Ethiop J Health Sci. 30(4): 623–638. doi: 10.4314/ejhs.v30i4.18.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in metaanalyses. BMJ. 327 (7414): 557–560. doi: 10.1136/bmj.327.7414.557.
Huber CA, Reich O (2016). Medication adherence in patients with diabetes mellitus: does physician drug dispensing enhance quality of care? Evidence from a large health claims database in Switzerland. Patient Prefer Adherence. 10: 1803–1809. doi: 10.2147/PPA.S115425.
Hugtenburg JG, Timmers L, Elders PJ, Vervloet M, van Dijk L (2013). Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence. 7: 675–682. doi: 10.2147/PPA.S29549.
Hutchins V, Zhang B, Fleurence RL, Krishnarajah G, Graham J (2011). A systematic review of adherence, treatment satisfaction and costs, in fixeddose combination regimens in type 2 diabetes. Curr Med Res Opin. 27(6): 1157–1168. doi: 10.1185/03007995.2011.570745.
Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JPA, et al. (2015). The PRISMA extension statement for reporting of systematic reviews incorporating network metaanalyses of health care interventions: checklist and explanations. Ann. Intern. Med. 162(11): 777–784. doi: 10.7326/M142385.
Jeannette A, Chris P, Esther J, Anoop M (2017). Diabetes atlas (8th ed).
Kalyango JN, Owino E, Nambuya AP (2008). Nonadherence to diabetes treatment at Mulago Hospital in Uganda: prevalence and associated factors. Afr. Health Sci. 8(2): 67–73.
Kardas P (2005). The DIACOM study (effect of Dosing frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes). Diabetes Obes Metab. 7(6): 722–728. doi:10.1111/j.14631326.2004.00462.x.
Moucheraud C, Lenz C, Latkovic M, Wirtz, VJ (2019). The costs of diabetes treatment in low and middleincome countries: a systematic review. In BMJ Glob. Health. 4(1): e001258. doi: 10.1136/bmjgh2018001258.
Nonogaki A, Heang H, Yi S, van Pelt M, Yamashina H, Taniguchi C, Nishida T, et al. (2019). Factors associated with medication adherence among people with diabetes mellitus in poor urban areas of Cambodia: A crosssectional study. PloS One. 14(11): e0225000. doi: 10.1371/journal.pone.0225000.
Pirdehghan A, Poortalebi N (2016). Predictors of Adherence to Type2 Diabetes Medication. J Res Med Sci. 16(2): 72–75.
Rothschild SK, Martin MA, Swider SM, Tumialán Lynas CM, Janssen I, Avery EF, Powell LH, et al. (2014). Mexican American trial of community health workers: a randomized controlled trial of a community health worker intervention for Mexican Americans with type 2 diabetes mellitus. Am. J. Public Health. 104(8): 1540–1548. doi: 10.2105/AJPH.2013.301439.
Rwegerera GM (2014). Adherence to antidiabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania A crosssectional study. Pan Afr Med J. 17: 252. doi: 10.11604/pamj.2014.17.252.2972.
Saleh F, Mumu SJ, Ara F, Begum HA, Ali L (2012). Knowledge and selfcare practices regarding diabetes among newly diagnosed type 2 diabetics in Bangladesh: a crosssectional study. BMC Public Health. 12: 1112. doi: 10.1186/14712458121112.
Schoenthaler AM, Schwartz BS, Wood C, Stewart WF (2012). Patient and physician factors associated with adherence to diabetes medications. Certified Diabetes Educator. 38(3): 397–408. doi: 10.1177/0145721712440333.
Sweileh WM, Zyoud SH, Abu Nab’a RJ, Deleq MI, Enaia MI, Nassar SM, AlJabi SW, et al. (2014). Influence of patients’ disease knowledge and beliefs about medicines on medication adherence: findings from a crosssectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health. 14: 94. doi: 10.1186/147124581494.
Tiv M, Viel JF, Mauny F, Eschwège E, Weill A, Fournier C, FagotCampagna A, et al. (2012). Medication adherence in type 2 diabetes: the ENTRED study 2007, a French PopulationBased Study. PloS One. 7(3): e32412. doi: 10.1371/journal.pone.0032412.
Webber S (2013). International Diabetes Federation. In Diabetes Res Clin Pract. 102(2). doi: 10.1016/j.diabres.2013.10.013.
WHO. (2016). Global report on diabetes. Geneva, Switzerland.
Widiyanto A (2017). Hubungan Kepatuhan Minum Obat dengan Kesembuhan Pasien Tuberkulosis Paru BTA Positif di Puskesmas Delanggu Kabupaten Klaten. Interest: JHS. 6(1): 712.
Widiyanto A, Murti B, Soemanto RB (2018). Multilevel analysis on the SocioCultural, lifestyle factors, and school environment on the risk of overweight in adolescents, Karanganyar district, central Java. J Epidemiol Public Health. 3(1): 94104. doi: 10.26911/jepublichealth.2018.03.01.08.
Wong MCS, Kong APS, So WY, Jiang JY, Chan JCN, Griffiths SM (2011). Adherence to oral hypoglycemic agents in 26,782 Chinese patients: a cohort study. J Clin Pharmacol. 51(10): 1474–1482. doi: 10.1177/0091270010382911.
Xu N, Xie S, Chen Y, Li J, Sun L (2020). Factors Influencing Medication NonAdherence among Chinese Older Adults with Diabetes Mellitus. Int. J. Environ. 17(17). doi: 10.3390/ijerph17176012.
